These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 18032526)
1. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. Cai W; He JC; Zhu L; Chen X; Striker GE; Vlassara H Am J Physiol Cell Physiol; 2008 Jan; 294(1):C145-52. PubMed ID: 18032526 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Cai W; He JC; Zhu L; Lu C; Vlassara H Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13801-6. PubMed ID: 16954185 [TBL] [Abstract][Full Text] [Related]
3. AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease. Cai W; Torreggiani M; Zhu L; Chen X; He JC; Striker GE; Vlassara H Am J Physiol Cell Physiol; 2010 Mar; 298(3):C624-34. PubMed ID: 19955485 [TBL] [Abstract][Full Text] [Related]
4. p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Guo J; Gertsberg Z; Ozgen N; Steinberg SF Circ Res; 2009 Mar; 104(5):660-9. PubMed ID: 19168439 [TBL] [Abstract][Full Text] [Related]
5. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Cai W; He JC; Zhu L; Chen X; Wallenstein S; Striker GE; Vlassara H Am J Pathol; 2007 Jun; 170(6):1893-902. PubMed ID: 17525257 [TBL] [Abstract][Full Text] [Related]
6. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Cai W; He JC; Zhu L; Chen X; Zheng F; Striker GE; Vlassara H Am J Pathol; 2008 Aug; 173(2):327-36. PubMed ID: 18599606 [TBL] [Abstract][Full Text] [Related]
7. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Nemoto S; Finkel T Science; 2002 Mar; 295(5564):2450-2. PubMed ID: 11884717 [TBL] [Abstract][Full Text] [Related]
8. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. Arany I; Faisal A; Nagamine Y; Safirstein RL J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162 [TBL] [Abstract][Full Text] [Related]
9. P53 Contributes to Cisplatin Induced Renal Oxidative Damage via Regulating P66shc and MnSOD. Yuan Y; Wang H; Wu Y; Zhang B; Wang N; Mao H; Xing C Cell Physiol Biochem; 2015; 37(4):1240-56. PubMed ID: 26431211 [TBL] [Abstract][Full Text] [Related]
10. Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Menini S; Iacobini C; Ricci C; Oddi G; Pesce C; Pugliese F; Block K; Abboud HE; Giorgio M; Migliaccio E; Pelicci PG; Pugliese G Diabetologia; 2007 Sep; 50(9):1997-2007. PubMed ID: 17611735 [TBL] [Abstract][Full Text] [Related]
11. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells. Zheng Z; Yang J; Zhao D; Gao D; Yan X; Yao Z; Liu Z; Ma Z FEBS J; 2013 Sep; 280(18):4522-30. PubMed ID: 23815759 [TBL] [Abstract][Full Text] [Related]
12. Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1. Yang SJ; Chen CY; Chang GD; Wen HC; Chen CY; Chang SC; Liao JF; Chang CH PLoS One; 2013; 8(3):e58100. PubMed ID: 23472139 [TBL] [Abstract][Full Text] [Related]
13. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Cai W; Ramdas M; Zhu L; Chen X; Striker GE; Vlassara H Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15888-93. PubMed ID: 22908267 [TBL] [Abstract][Full Text] [Related]
14. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. Li M; Chiu JF; Gagne J; Fukagawa NK J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585 [TBL] [Abstract][Full Text] [Related]
15. Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins. Haga S; Terui K; Fukai M; Oikawa Y; Irani K; Furukawa H; Todo S; Ozaki M J Hepatol; 2008 Mar; 48(3):422-32. PubMed ID: 18191273 [TBL] [Abstract][Full Text] [Related]
16. Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species. Vikram A; Kim YR; Kumar S; Naqvi A; Hoffman TA; Kumar A; Miller FJ; Kim CS; Irani K Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2301-9. PubMed ID: 25147340 [TBL] [Abstract][Full Text] [Related]
17. Genistein protects against UVB-induced senescence-like characteristics in human dermal fibroblast by p66Shc down-regulation. Wang YN; Wu W; Chen HC; Fang H J Dermatol Sci; 2010 Apr; 58(1):19-27. PubMed ID: 20211546 [TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells. Xi G; Shen X; Radhakrishnan Y; Maile L; Clemmons D Endocrinology; 2010 Aug; 151(8):3611-23. PubMed ID: 20534722 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling. Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688 [TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Alikhani M; Maclellan CM; Raptis M; Vora S; Trackman PC; Graves DT Am J Physiol Cell Physiol; 2007 Feb; 292(2):C850-6. PubMed ID: 17005604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]